Comparison of Ultrasound-guided Intraarticular Hip Injections With and Without Prior Local Anesthesia

Hip Pain Clinical Trial

Official title:

Comparison of Ultrasound-guided Intraarticular Hip Injections With and Without Prior Local Anesthesia: a Randomized Controlled Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05209399
• Other study ID #: STUDY00006887
• Status: Completed
• Phase: N/A
• Start date: June 30, 2022
• Est. completion date: May 10, 2023

Study information

• Verified date: June 2023
• Source: University of Rochester
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this single-center randomized controlled trial, subjects undergoing a first-time ultrasound-guided unilateral intraarticular hip injection will be randomized into one of two groups: hip injection with prior local anesthesia (With LA) or hip injection without prior local anesthesia (Without LA). Visual analog scale (VAS) pain scores (0-100) will be collected after the local anesthesia injection (With LA group) and intraarticular hip injection (both groups). The primary outcome measure for comparison between the two groups will be VAS score for the intraarticular hip injection.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 42
• Est. completion date: May 10, 2023
• Est. primary completion date: May 10, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients undergoing a first-time ultrasound-guided unilateral intraarticular hip injection

• Subjects must be fluent in English

• Subject must be able to consent for themselves and mark pain levels on a visual analog scale.

Exclusion Criteria:

• previous intraarticular hip injection (to remove bias from prior injection experiences)

• prior surgery on the hip to be injected

• use of opioid medication on the day of or day before the procedure

• diabetes mellitus

• body mass index (BMI) greater than 40

Related Conditions & MeSH terms

• Hip Pain

Intervention

Procedure:
• Ultrasound guided injection
All intraarticular hip injections will be performed under real-time ultrasound guidance using a GE LOGIQ P9 ultrasound machine with a C1-5-RS 1-5 MHz curvilinear transducer (GE Healthcare, Chicago, IL, USA). For the procedure, patients will be placed in a supine position. The curvilinear transducer and ultrasound machine will be used to visualize the anterior aspect of the hip joint in a sagittal oblique plane. Sterile technique will be used to perform the procedure.

Locations

Country	Name	City	State
United States	University of Rochester Medical Center Physical Medicine and Rehabilitation	Rochester	New York

Sponsors (2)

Lead Sponsor	Collaborator
University of Rochester	American Medical Society for Sports Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	mean pain score	A visual analog pain score will be collected. The scale of the score is 0-100 with 100 indicating more pain.	baseline